Should Patients with Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target?: A Protagonist View from the SPRINT Trial (Systolic Blood Pressure Intervention Trial)

Circulation

Volumn 134, Issue 18, 2016, Pages 1308-1310

  Oparil, Suzanne ^a   Lewis, Cora E ^b  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

blood pressure; blood pressure measurement monitoring; clinical trial; high blood pressure; hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL OUTCOME; CLINICAL TRIAL (TOPIC); HUMAN; HYPERTENSION; INTENSIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; AGED; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PARASITOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX FACTOR; SURVIVAL RATE;

AGED; BLOOD PRESSURE; DISEASE-FREE SURVIVAL; HUMANS; HYPERTENSION; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 84988615494     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.023263     Document Type: Short Survey

References (5)

1. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-2116. doi: 10. 1056/NEJMoa1511939.
2. Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged 75 years: A randomized clinical trial. JAMA. 2016;315:2673-2682. doi: 10. 1001/jama. 2016. 7050.
3. Bress AP, Tanner RM, Hess R, Colantonio LD, Shimbo D, Muntner P. Generalizability of results from the Systolic Blood Pressure Intervention Trial (SPRINT) to the US adult population. J Am Coll Cardiol. 2016;67:463-472. doi: 10. 1016/j. jacc. 2015. 10. 037.
4. Margolis KL, O'Connor PJ, Morgan TM, Buse JB, Cohen RM, Cushman WC, Cutler JA, Evans GW, Gerstein HC, Grimm RH Jr, Lipkin EW, Narayan KM, Riddle MC Jr, Sood A, Goff DC Jr. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: The ACCORD randomized trial. Diabetes Care. 2014;37:1721-1728. doi: 10. 2337/dc13-2334.
5. Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016;32:569-588. doi: 10. 1016/j. cjca. 2016. 02. 066.